Comparison of hollow fibre membrane oxygenators during cardiopulmonary bypass in children: Dideco Masterflo versus Terumo Capiox II

Abstract

This prospective study was planned to compare two different (reversed blood and gaseous compartments) hollow fibre membrane oxygenators, Dideco Masterflo and Terumo Capiox II, in order to find out which of these oxygenators was less injurious during cardiopulmonary bypass (CPB) surgery in small children. Twenty children underwent CPB surgery for complex congenital cardiac malformations. Ten patients were selected for each study group by matching age and weight. Oxygenators were the only variables in the CPB circuit, and special attention was focused on the kinetics of white blood cell count (WBC), complement C3, anaphylatoxin C3a, total haemolytic complement (CH100), C-reactive protein (CRP) and haptoglobin. There were no significant differences between the parameters studied at any sample time. However, there was less intense C3a (peak C3a levels 2506 ± 1187 SD versus 4302 ± 3958 SD; p = 0.19) generation, and also less intense CH100 consumption (percentual drop of initial CH100 values was 30% versus 55.2%) in the Dideco Masterflo group of patients. Moreover, postoperative respiratory treatment was somewhat shorter when using Masterflo oxygenators (2.4 ± 2.41 SD versus 4.0 ± 2.49 SD days; p = 0.16), although statistical significance was not obtained. These findings may be important in high-risk paediatric patients undergoing open-heart surgery.

Get full access to this article

View all access options for this article.

References

Chenoweth DE , Cooper SW , Hugli TE , Stewart RW , Blackstone EH , Kirklin JW Complement activation during cardiopulmonary bypass. N Engl J Med 1981; 304: 497-503.

Kirklin JK , Blackstone EH , Kirklin JW , McKay R. , Pacifico AD , Bargeron LM Intracardiac surgery in infants under age 3 months: incremental risk factors for hospital mortality. Am J Cardiol 1981; 48: 500-506.

Kirklin JK , Westaby S. , Blackstone EH , Kirklin JW , Chenoweth DE , Pacifico AD Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845-57.

Cavarocchi NC , Pluth JR , Schaff HV Complement activation during cardiopulmonary bypass. Comparison of bubble and membrane oxygenators. J Thorac Cardiovasc Surg 1986; 91: 252-58.

van Oeveren W. , Kazatchkine MD , Descamps-Latscha B. et al. Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation . J Thorac Cardiovasc Surg 1985; 89: 888-99.

Hugli TE , Chenoweth DE Biologically active peptides of complement techniques and significance of C3a and C5a measurement: future perspectives in clinical laboratory immunoassays . In: Nakamura RM , Dito WR , Tucker ES III eds, Clinic laboratory techniques for the 1980s, New York: Liss, 1980 ; 443-460.

Craddock PR Hammerschmidt D. , White JG , Dalmasso AP , Jacob HS Complement (C5a)-induced granulocyte aggregation in vitro. A possible mechanism of complement mediated leukostasis and leukopenia. J Clin Invest 1977; 60: 260-64.

Jacob HS Complement mediated leukoembolization. A mechanism of tissue damage during extracorporeal perfusions, myocardial infarction and in shock: a review. Q J Med 1983; 52: 289-96.

Meri S. , Aronen M. , Leijala M. Complement activation during cardiopulmonary bypass in children. Complement 1988; 5: 46-54.

10.

Hammerschmidt DE , Stroncek DF , Bowers TK et al. Complement activation and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1981; 81: 370-77.

11.

Wagner JL , Hugli TE Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids. Analytical Biochemistry 1984; 136: 75-88.

12.

Collett B. , Alhaq A. , Abdullah NB Pathways to complement activation during cardiopulmonary bypass. Br Med J 1984; 289: 1251-54.

13.

Fosse E. , Mollnes TE , Ingvaldsen B. Complement activation during major operations with or without cardiopulmonary bypass. J Thorac Cardiovasc Surg 1987; 93: 860-66.

14.

Ghoneim Atm , McGolldrik J. , lonescu MI Serial C-reactive protein measurements in infective complications following cardiac operations: evaluation and use in monitoring response to therapy. Ann Thorac Surg 1982; 34: 166-75.

15.

Siegel J. , Rent R. , Gewurz H. Interactions of C-reactive protein with the complement system. J Exp Med 1974; 140: 631-47.